Figure 4From: Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2 Regression analysis showed a significant correlation between the area of metastatic lung nodules and tumor volume regardless of treatment. Back to article page